[Retracted] The Influence of ICAM1 3′UTR Gene Polymorphism on the Occurrence and Metastasis of Primary Liver Cancer

Table 4

Stratified analysis of the correlation between SNP at rs923366 of the ICAM1 gene and PHC susceptibility risk.

	PHC ()	Control ()	OR (95% CI)	value
Age [years, (%)]
<60
CC	90 (66.18%)	75 (53.57%)	1.00 (reference)
CT+TT	46 (33.82%)	65 (46.43%)	0.59 (0.36-0.96)	0.04
≥60
CC	105 (68.18%)	79 (52.67%)	1.00 (reference)
CT+TT	49 (31.82%)	71 (47.33%)	0.52 (0.33-0.83)	<0.01
Gender [ (%)]
Male
CC	99 (60.74%)	96 (57.83%)	1.00 (reference)
CT+TT	64 (39.26%)	70 (42.17%)	0.89 (0.57-1.38)	0.67
Female
CC	96 (75.59%)	58 (46.77%)	1.00 (reference)
CT+TT	31 (24.41%)	66 (53.23%)	0.28 (0.17-0.49)	<0.01
BMI [kg/m^2, (%)]
<25
CC	108 (73.47%)	92 (52.57%)	1.00 (reference)
CT+TT	39 (26.53%)	83 (47.43%)	0.40 (0.25-0.64)	<0.01
≥25
CC	87 (60.84%)	62 (53.91%)	1.00 (reference)
CT+TT	56 (39.16%)	53 (46.09%)	0.75 (0.46-1.24)	0.32
Smoking [ (%)]
No
CC	93 (74.40%)	93 (53.45%)	1.00 (reference)
CT+TT	32 (25.60%)	81 (46.55%)	0.40 (0.24-0.65)	<0.01
Yes
CC	102 (61.82%)	61 (52.59%)	1.00 (reference)
CT+TT	63 (38.18%)	55 (47.41%)	0.69 (0.42-1.11)	0.16
Drinking [ (%)]
No
CC	83 (69.75%)	90 (57.69%)	1.00 (reference)
CT+TT	36 (30.18%)	66 (42.31%)	0.59 (0.36-0.98)	0.04
Yes
CC	112 (65.50%)	64 (47.76%)	1.00 (reference)
CT+TT	59 (34.50%)	70 (52.24%)	0.48 (0.30-0.77)	<0.01
Family history of cancer [ (%)]
No
CC	158 (67.23%)	146 (52.52%)	1.00 (reference)
CT+TT	77 (32.77%)	132 (47.48%)	0.54 (0.38-0.77)	<0.01
Yes
CC	37 (67.27%)	8 (66.67%)	1.00 (reference)
CT+TT	18 (32.77%)	4 (33.33%)	0.97 (0.26-3.66)	0.97
Hepatitis B virus [ (%)]
Negative
CC	36 (67.92%)	139 (54.51%)	1.00 (reference)
CT+TT	17 (32.08%)	116 (45.49%)	0.57 (0.30-1.06)	0.10
Positive
CC	159 (67.09%)	15 (42.86%)	1.00 (reference)
CT+TT	78 (32.91%)	20 (57.14%)	0.37 (0.18-0.76)	<0.01

Adjust factors such as BMI, smoking, drinking, family history of tumors, and hepatitis B virus. OR: odds ratio; CI: confidence interval.